,,ii  #aae? ,,congress  #b;d ,session   
,s4 #bdea  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,febru>y #bf1 #bjah,mr4
 ,cassidy introduc$ ! foll[+ bill2 :i* 0
 read twice & ref]r$ to ! ,committee on 
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to require ! ,secret>y (    
,heal? & ,human ,s]vices to consid]     
,/ate analysis & %>+ ( prescription drug
 monitor+ program data 9 det]m9+        
prescription drug monitor+ program      
grants to ,/ates4  #a4 ,%ort title ,?is 
,act may be cit$ z ! ,protection f      
,ov]prescrib+ ,act4  #b4 ,consid]ation 9
 aw>d+ grants to support ,/ate ,p,d,m,ps
 ,9 det]m9+ :e!r to aw>d a grant to a   
,/ate 9 support ( a ,/ate prescription  
drug monitor+ program1 ! ,secret>y (    
,heal? & ,human ,s]vices %all consid]   
:e!r ea* ag5cy ( ! ,/ate t adm9i/]s !   
prescription drug monitor+ program      
proactively analyzes data available     
?r\gh ! ,/ate's prescription drug       
monitor+ program & provides reports to  
law en=cem5t ag5cies1 prescrib] lic5s+  

bo>ds1 & o!r ag5cies describ+ any       
prescrib]s t repeat$ly fall outside (   
expect$ norms or /&>d practices = !     
prescrib]'s field4